Immutep Ltd Files Form 6-K
Ticker: PRRUF · Form: 6-K · Filed: Sep 3, 2024 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Sep 3, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, corporate-update
TL;DR
Immutep Ltd (formerly Prima BioMed) filed a 6-K on Aug 30, 2024. Standard foreign issuer report.
AI Summary
Immutep Limited filed a Form 6-K on September 3, 2024, reporting information as of August 30, 2024. The company, formerly known as Prima BioMed Ltd, is based in Sydney, Australia, and operates in the pharmaceutical preparations sector. This filing is a routine report for foreign private issuers.
Why It Matters
This filing provides an update on Immutep's regulatory status and corporate information as a foreign private issuer, which is important for investors tracking the company's compliance and reporting.
Risk Assessment
Risk Level: low — This filing is a routine administrative report for a foreign private issuer and does not contain new financial or operational information that would typically indicate significant risk.
Key Players & Entities
- IMMUTEP Ltd (company) — Filer
- Prima BioMed Ltd (company) — Former company name
- August 30, 2024 (date) — Date of report
- September 3, 2024 (date) — Filing date
- Sydney, Australia (location) — Company headquarters
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, providing information that the company has made or is required to make public in its home country.
When was Immutep Limited previously known by another name?
Immutep Limited was formerly known as Prima BioMed Ltd, with a date of name change on November 19, 2010.
What is Immutep Limited's Standard Industrial Classification (SIC) code?
Immutep Limited's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Immutep Limited's principal executive office located?
Immutep Limited's principal executive office is located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
Does Immutep Limited file its annual reports under Form 20-F or Form 40-F?
Immutep Limited indicates that it files its annual reports under cover of Form 20-F.
Filing Stats: 254 words · 1 min read · ~1 pages · Grade level 16.8 · Accepted 2024-09-03 06:05:57
Filing Documents
- d852554d6k.htm (6-K) — 9KB
- d852554dex991.htm (EX-99.1) — 1387KB
- g852554dsp40.jpg (GRAPHIC) — 6KB
- g852554dsp97a.jpg (GRAPHIC) — 19KB
- g852554g0830093451765.jpg (GRAPHIC) — 2KB
- g852554g0830093452035.jpg (GRAPHIC) — 3KB
- g852554g0830093452366.jpg (GRAPHIC) — 2KB
- g852554g0830093452576.jpg (GRAPHIC) — 2KB
- g852554g0830093452757.jpg (GRAPHIC) — 1KB
- g852554g97a01.jpg (GRAPHIC) — 29KB
- 0001193125-24-211469.txt ( ) — 1487KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: August 30, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer